Wilkinson, D. S., Wilson, J., Lerner, E. C., Ryan, K., Chandramohan, V., Bigner, D., & Fecci, P. E. (2025). D2C7 CAR specifically targets tumor-associated EGFR and is effective against peripheral and intracranial cancers 3321. In The Journal of Immunology (Vol. 214). Oxford University Press (OUP). https://doi.org/10.1093/jimmun/vkaf283.1137

Wilkinson, Daniel S., Joseph Wilson, Emily C. Lerner, Ketherine Ryan, Vidyalakshmi Chandramohan, Darell Bigner, and Peter E. Fecci. “D2C7 CAR specifically targets tumor-associated EGFR and is effective against peripheral and intracranial cancers 3321.” In The Journal of Immunology, Vol. 214. Oxford University Press (OUP), 2025. https://doi.org/10.1093/jimmun/vkaf283.1137.

Wilkinson DS, Wilson J, Lerner EC, Ryan K, Chandramohan V, Bigner D, et al. D2C7 CAR specifically targets tumor-associated EGFR and is effective against peripheral and intracranial cancers 3321. In: The Journal of Immunology. Oxford University Press (OUP); 2025.

Wilkinson, Daniel S., et al. “D2C7 CAR specifically targets tumor-associated EGFR and is effective against peripheral and intracranial cancers 3321.” The Journal of Immunology, vol. 214, no. Supplement_1, Oxford University Press (OUP), 2025. Crossref, doi:10.1093/jimmun/vkaf283.1137.

Wilkinson DS, Wilson J, Lerner EC, Ryan K, Chandramohan V, Bigner D, Fecci PE. D2C7 CAR specifically targets tumor-associated EGFR and is effective against peripheral and intracranial cancers 3321. The Journal of Immunology. Oxford University Press (OUP); 2025.